台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    78.9
  • 漲跌
    ▲1.1
  • 漲幅
    +1.41%
  • 成交量
    880
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
中裕 (4147)籌碼相關-元大-長庚 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/1005/2406/0806/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0402/1803/0203/1203/2404/0604/1601/1602/0660708090100110120May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

元大-長庚 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/14577.50577.5077.2002,3750.00%
2025/04/02189.7000.0087.9012,2940.04%
2025/03/2800.000.495.5293.80-0.42,257-0.02%
2025/03/27096.6000.0096.1002,2480.00%
2025/03/260.199.0000.0098.100.12,2300.01%
2025/03/255.397.5900.0098.605.32,2100.24%
2025/03/24299.10799.4099.00-52,192-0.23%
2025/03/2100.004096.5796.40-402,149-1.86%
2025/03/18291.30291.8091.9002,0850.00%
2025/03/132093.50493.5091.60162,0990.76%
2025/03/12195.80295.0097.50-12,060-0.05%
2025/03/112894.652295.4995.6062,0410.29%
2025/03/072097.5000.0096.50201,9911.00%
2025/03/06297.00294.7094.3001,9570.00%
2025/03/05297.25498.4098.60-21,924-0.10%
2025/03/03294.80294.1094.2001,8870.00%
2025/02/27298.050.596.7095.501.61,8780.08%
2025/02/267.198.80798.6098.000.11,8860.00%
2025/02/251.4100.101100.5099.300.41,8560.02%
2025/02/2400.002100.0099.30-21,796-0.11%
2025/02/2110100.87198.8098.9091,7270.52%
2025/02/20196.50895.4099.70-71,553-0.45%
2025/02/191094.5014.395.4895.20-4.31,510-0.28%
2025/02/182193.930.395.0094.0020.71,4911.39%
2025/02/172.3108.06199.7097.101.31,4400.09%
2025/02/14199.001699.5998.90-151,226-1.22%
2025/02/13294.2500.0094.0021,1520.17%
2025/02/10089.6000.0089.9001,1290.00%
2025/02/07089.9000.0090.1001,1250.00%
2025/02/06186.8000.0087.8011,1150.09%
2025/02/04385.8000.0083.3031,1140.27%
2025/01/09488.90488.4587.5001,0140.00%
2025/01/08199.1000.0097.2018720.11%
2025/01/0700.001792.6692.70-17649-2.62%
2024/10/2200.00381.3080.60-3562-0.53%
2024/10/09174.5000.0073.9016220.16%
2024/10/08177.0000.0076.3016180.16%
2024/09/26180.9000.0080.2016500.15%
2024/08/1500.00379.7080.00-3775-0.39%
2024/07/3000.00182.4083.90-1737-0.14%
2024/07/191289.99190.2086.50117271.51%
2024/07/1700.00187.5088.10-1713-0.14%
2024/07/16186.7000.0085.6017200.14%
2024/07/0100.00290.1090.20-21,096-0.18%
2024/06/25187.2000.0087.8011,1210.09%
2024/06/19191.5000.0089.5011,1360.09%
2024/04/3000.00084.8085.5002,3290.00%
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-7天前
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-21天前
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕 相關文章